US00974B1070 - Common Stock
AKLI stock results show that Akili beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akili (NASDAQ:AKLI) just reported results for the first quarter of 2024.Akili r...
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
AGBA Group stock is gaining on Tuesday as investors celebrate an update on the company's $4 billion merger with Triller.
Which stocks are experiencing notable movement on Tuesday?
Akili stock is taking off on Tuesday as AKLI investors celebrate $5 million of its debt being forgiven alongside a $10.5 million payment.
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!
Akili has announced a positive update regarding its ADHD treatment. Here's why AKLI stock is up over 100% on the news.
Akili (AKLI) stock rallied 130% Monday on news that partner Shionogi has submitted an application for Japanese regulatory approval of its digital therapeutic SDT-001 for ADHD.